That is the pitch
GLP-1 can be used for weight loss and as a treatment for type 2 diabetes
A spokeswoman for Novo Nordisk, the Danish company that makes Ozempic and Wegovy, says the company does not promote, suggest, or encourage off-label use of our medicines. We trust that healthcare providers are evaluating a patients individual needs and determining which medicine is right for that particular patient, Allison Schneider wrote in a statement
Eur J Clin Pharmacol (1991) 40:S538
If you have type 2 diabetes, your doctor may recommend Semaglutide GLP-1 injections if you are having difficulties controlling your blood sugar levels or are at a high risk of developing complications such as heart disease
Wegovy and Ozempic, the brand names for semaglutide, cost similarly, ranging from nine hundred to twelve hundred dollars monthly